{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:50:29Z","timestamp":1790351429132,"version":"4.1.0"},"reference-count":71,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/16078454.2023.2284038","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:01:07Z","timestamp":1700478067000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["A review on characterization of BCR \u2013 ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes"],"prefix":"10.1080","volume":"28","author":[{"given":"Benyam","family":"Zenebe","sequence":"first","affiliation":[{"name":"Microbial Cellular and Molecular Biology Department, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nigussie","sequence":"additional","affiliation":[{"name":"Microbial Cellular and Molecular Biology Department, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurja","family":"Belay","sequence":"additional","affiliation":[{"name":"Microbial Cellular and Molecular Biology Department, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigussie","family":"Seboka","sequence":"additional","affiliation":[{"name":"Microbial Cellular and Molecular Biology Department, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62120-0"},{"key":"e_1_3_2_3_1","first-page":"2155","article-title":"The global incidence and prevalence of chronic myeloid leukemia over the next ten years (2017\u20132027)","volume":"8","author":"Tadwalkar S.","year":"2017","unstructured":"Tadwalkar S. The global incidence and prevalence of chronic myeloid leukemia over the next ten years (2017\u20132027). J Blood DisordTransfus. 2017;8:2155\u20132164.","journal-title":"J Blood DisordTransfus"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.809"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.1.204-213.1985"},{"issue":"3","key":"e_1_3_2_6_1","first-page":"151","article-title":"Interpreting molecular monitoring results and international standardization in chronic myeloid leukemia","volume":"3","author":"Bauer S","year":"2012","unstructured":"Bauer S, Romvari E. Interpreting molecular monitoring results and international standardization in chronic myeloid leukemia. J Adv Pract Oncol. 2012;3(3):151.","journal-title":"J Adv Pract Oncol"},{"issue":"1748","key":"e_1_3_2_7_1","first-page":"10","article-title":"Detection of BCR\u2013ABL fusion gene and its transcript variants in chronic myeloid leukaemia patients\u2013a multi \u2013 comparison study","volume":"70","author":"Javed A","year":"2020","unstructured":"Javed A, Mukhtar H, Kubra K, et al. Detection of BCR\u2013ABL fusion gene and its transcript variants in chronic myeloid leukaemia patients\u2013a multi \u2013 comparison study. JPMA. 2020;70(1748):10\u20135455.","journal-title":"JPMA"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246141"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.08.020"},{"key":"e_1_3_2_10_1","first-page":"29","article-title":"Fusion gene BCR-ABL: from etiopathogenesis to the management of chronic myeloid leukemia","author":"Sholikah T.A.","year":"2017","unstructured":"Sholikah, T.A. (2017). Fusion gene BCR-ABL: from etiopathogenesis to the management of chronic myeloid leukemia. JKKI: Jurnal Kedokteran dan Kesehatan Indonesia: 29-37.","journal-title":"JKKI: Jurnal Kedokteran dan Kesehatan Indonesia"},{"issue":"6","key":"e_1_3_2_11_1","first-page":"720","article-title":"Multiplex PCR for identifying BCR-ABL fusion transcript types in Northeastern Thailand chronic myeloid leukemia patients","volume":"35","author":"Chootawiriyasakul K","year":"2020","unstructured":"Chootawiriyasakul K, Chansung K. Multiplex PCR for identifying BCR-ABL fusion transcript types in Northeastern Thailand chronic myeloid leukemia patients. Srinagarind Med J. 2020;35(6):720\u2013725.","journal-title":"Srinagarind Med J"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00170-6"},{"issue":"1","key":"e_1_3_2_13_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell PC","year":"1960","unstructured":"Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25(1):85\u2013109.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241318"},{"key":"e_1_3_2_15_1","volume-title":"Statpearls [internet]","author":"Haider MZ","year":"2023","unstructured":"Haider MZ, Anwer F. Genetics, Philadelphia chromosome [Updated 2023 July 17]. In: Statpearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023 January. Available from: https:\/\/www.ncbi.gov\/books\/NBK560689."},{"issue":"10","key":"e_1_3_2_16_1","first-page":"3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger MW","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood J Am Soc Hematol. 2000;96(10):3343\u20133356.","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981952"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-016-0108-0"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280581"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2017.08.002"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb11157.x"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071545"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.811"},{"issue":"2","key":"e_1_3_2_24_1","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Shuai K","year":"1996","unstructured":"Shuai K, Halpern J, Ten Hoeve J, et al. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene. 1996;13(2):247\u2013254.","journal-title":"Oncogene"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203476"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.20.6151"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000329"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06319.x"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4312"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.66"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.129"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2325-z"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.309"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.8.2038.2038"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000165"},{"issue":"1","key":"e_1_3_2_36_1","first-page":"8","article-title":"Chronic myeloid leukaemia in the 21st century","volume":"76","author":"Frazer R","year":"2007","unstructured":"Frazer R, Irvine AE, McMullin MF. Chronic myeloid leukaemia in the 21st century. Ulster Med J. 2007;76(1):8.","journal-title":"Ulster Med J"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206082"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0654-8"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0822-7"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-008-1100-8"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.671296"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.193"},{"issue":"8","key":"e_1_3_2_43_1","first-page":"2828","article-title":"How I treat chronic myeloid leukemia in the imatinib era","volume":"110","author":"Goldman JM.","year":"2007","unstructured":"Goldman JM. How I treat chronic myeloid leukemia in the imatinib era. Blood J Am Soc Hematol. 2007;110(8):2828\u20132837.","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41246"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2013.01.002"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2013.05.010"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030620"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2003.50044"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-71913-5_8"},{"issue":"22","key":"e_1_3_2_50_1","first-page":"e111","article-title":"Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA","volume":"116","author":"White HE","year":"2010","unstructured":"White HE, Matejtschuk P, Rigsby P, et al. Establishment of the first World Health Organization international genetic reference panel for quantitation of BCR-ABL mRNA. Blood J Am Soc Hematol. 2010;116(22):e111\u2013e117.","journal-title":"Blood J Am Soc Hematol"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15542"},{"key":"e_1_3_2_52_1","article-title":"Impact of the major BCR\u2013ABL1 transcript type on clinical and biological parameters and molecular response in patients with chronic myeloid leukemia","author":"Nachi M","year":"2022","unstructured":"Nachi M, Kihel I, Entasoltane B, et al. Impact of the major BCR\u2013ABL1 transcript type on clinical and biological parameters and molecular response in patients with chronic myeloid leukemia. Hematology\/Oncology and Stem Cell Therapy. 2022.15:Iss.2, Article 9.","journal-title":"Hematology\/Oncology and Stem Cell Therapy"},{"issue":"1","key":"e_1_3_2_53_1","first-page":"186","article-title":"An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders","volume":"8","author":"Cross NC","year":"1994","unstructured":"Cross NC, Melo JV, Feng L, et al. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia. 1994;8(1):186\u2013189.","journal-title":"Leukemia"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(21)01195-2"},{"issue":"6","key":"e_1_3_2_55_1","first-page":"872","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani M","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood, J Am Soc Hematol. 2013;122(6):872\u2013884.","journal-title":"Blood, J Am Soc Hematol"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716657994"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-947-QAOTBT"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000293"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2256199"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80003-0"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.096537"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.6.1545"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1515\/med-2021-0309"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0348-z"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2011.e3"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.08.017"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15453"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13918"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100825"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31977"},{"issue":"10","key":"e_1_3_2_71_1","first-page":"1269","article-title":"Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors","volume":"127","author":"Jain P","year":"2016","unstructured":"Jain P, Kantarjian H, Patel KP, et al. Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors. Blood, J Am Soc Hematol. 2016;127(10):1269\u20131275.","journal-title":"Blood, J Am Soc Hematol"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8420853"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/16078454.2023.2284038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:06:24Z","timestamp":1702296384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16078454.2023.2284038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/16078454.2023.2284038"],"URL":"https:\/\/doi.org\/10.1080\/16078454.2023.2284038","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2284038"}}